Merit Medical Systems Inc(MMSI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 38.83 | EPS (ttm) | 2.43 | Insider Own | 2.6% | Shs Outstand | 59.7M | Perf Week | 4.71% |
| Market Cap | 5.62B | Forward P/E | 20.43 | EPS next Y | 7.2% | Insider Trans | -1.56% | Shs Float | 58.2M | Perf Month | 7.66% |
| Enterprise Value | 5.99B | PEG | 2.26 | EPS next Q | 1.04 | Inst Own | 105.52% | Short Float | 6.24% | Perf Quarter | 20.32% |
| Income | 0.15B | P/S | 3.56 | EPS this Y | 12.33% | Inst Trans | 3.43% | Short Ratio | 4.6 | Perf Half Y | 39.7% |
| Sales | 1.58B | P/B | 3.35 | EPS next 5Y | 9.02% | ROA | 5.34% | Short Interest | 3.63M | Perf YTD | 6.88% |
| Book/sh | 28.13 | P/C | 12.47 | EPS past 3/5Y | 18.04% - | ROE | 9.19% | 52W High | -0.58% ($94.75) | Perf Year | 13.85% |
| Cash/sh | 7.55 | P/FCF | 27.68 | Sales past 3/5Y | 9.7% 9.46% | ROIC | 5.85% | 52W Low | 57.68% ($59.74) | Perf 3Y | 48.37% |
| Dividend Est. | - | EV/EBITDA | 17.82 | EPS Y/Y TTM | 20.67% | Gross Margin | 49.43% | Volatility(W/M) | 2.4% 2.49% | Perf 5Y | 36.4% |
| Dividend TTM | - | EV/Sales | 3.79 | Sales Y/Y TTM | 10.51% | Oper. Margin | 12.69% | ATR (14) | 2.22 | Perf 10Y | 317.74% |
| Dividend Ex-Date | - | Quick Ratio | 2.79 | EPS Q/Q | 20.3% | Profit Margin | 9.21% | RSI (14) | 68.4 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.2 | Sales Q/Q | 9.83% | SMA20 | 6.26% ($88.65) | Beta | 0.55 | Target Price | $101.64 |
| Payout | - | Debt/Eq | 0.49 | Earnings | 2026/10/29 | SMA50 | 6.42% ($88.52) | Rel Volume | 1.27 | Prev Close | $93.3 |
| Employees | 7500 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 24.09% 3.36% | SMA200 | 22.69% ($76.78) | Avg Volume(3M) | 0.79M | Price | $94.2 |
| IPO | 1990/5/14 | Option/Short | Yes/Yes | Trades | 12318 | Volume | 1,001,120 | Change | 0.96% |
🩺 A global medical device company that manufactures single-use medical devices. The company manufactures and sells devices for cardiovascular and peripheral vascular procedures, endoscopes, and single-use medical devices for diagnostic and interventional procedures, and is exposed to recurring demand driven by the growing volume of procedures. It is a specialist company in the single-use medical device sector.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded more than usual. That is 127% of its average volume.
Next earnings report: October 29
2 days to go.
MMSI makes money exceptionally well
Of every $100 in sales, $12.69 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.3% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,782. Peers typically go for $1,583. Compared with its own 5-year average, it is 18% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +36.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 105.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #16 of 51 in the industry
Based on market cap of $6B.
FAQ
What kind of company is MMSI?
MMSI belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of MMSI?
The market cap of MMSI is approximately $5.6B, ranking 1,264 within its sector.
What is the P/E ratio of MMSI?
MMSI has a P/E ratio of approximately 38.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MMSI?
MMSI has recorded a 52-week high of $94.75 and a low of $59.74.